Industry
Johnson & Johnson Requires Claims Data Sharing for 340B Discounts
Johnson & Johnson is requiring 340B-covered entities to share claims data as a condition of receiving 340B drug discounts. The company joins other pharmaceutical manufacturers implementing reporting requirements, citing concerns about duplicate discounts. The policy affects safety-net providers that rely on 340B pricing, including federally qualified health centers and disproportionate share hospitals that serve Medicaid populations. The requirement takes effect immediately for providers seeking to maintain access to J&J's discounted pricing under the 340B program.
Why it mattersThe data-sharing mandate directly affects safety-net providers serving Medicaid beneficiaries by adding administrative burden and potentially limiting 340B savings used to fund care delivery and wraparound services.